Gastroenteritis hospitalizations in adults reduced since start of infant rotavirus vaccination

The researchers found that compared with prevaccine years, during 2008-2010, statistically significant reductions were observed in rotavirus-coded discharges in the age groups 0-4 years; 5-14 years; and 15-24 years. Similarly, significant reductions were observed in cause-unspecified discharges in the age groups 0-4 years; 5-14 years; 15-24 years; and 25-44 years.

"Implementation of infant rotavirus vaccination in 2006 has substantially reduced the burden of severe among U.S. children younger than 5 years," write Paul A. Gastanaduy, M.D., M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues. "Whether indirect protection (due to reduced transmission of rotavirus) extends to adults remains unclear."

As reported in a Research Letter, the authors assessed patterns of gastroenteritis hospitalizations among children 5 years of age or older and among adults before and after implementation of infant rotavirus immunization. Rotavirus-coded and cause-unspecified gastroenteritis discharges from January 2000 through December 2010 were retrieved from a nationally representative database of hospital inpatient stays, the Nationwide Inpatient Sample. Estimates were determined of annual and monthly incidence rate ratios (RR) of the postvaccine years (2008, 2009, and 2010) separately and combined vs. the prevaccine years (2000-2006); 2007 was a transition year with limited coverage and was excluded.

The researchers found that compared with prevaccine years, during 2008-2010, statistically significant reductions were observed in rotavirus-coded discharges in the age groups 0-4 years; 5-14 years; and 15-24 years. Similarly, significant reductions were observed in cause-unspecified discharges in the age groups 0-4 years; 5-14 years; 15-24 years; and 25-44 years. "Compared with prevaccine years, significant reductions in rotavirus-coded discharges occurred up to age 25 years in 2008, age 15 years in 2009, and across all age groups in 2010, with similar patterns for cause-unspecified discharges. Cause-unspecified reductions across all age groups and postvaccine years were focused in the late winter and early spring; in 2010, significant reductions were observed in March or April for all ."

"The pattern of observed reductions in gastroenteritis discharges among unvaccinated older children and adults is consistent with indirect protection resulting from infant rotavirus vaccination," the authors write. "These results point to the primacy of children in the transmission of rotavirus and illustrate how indirect benefits may amplify the effect of the U.S. rotavirus vaccination program."

More information: DOI: 10.1001/jama.2013.170800

add to favorites email to friend print save as pdf

Related Stories

Engineered rice protects against rotavirus infection

Aug 08, 2013

For children and immune compromised adults in developing countries, diarrheal disease induced by rotavirus can be life threatening. Current rotaviral vaccines are highly effective in the Western world, but are not as effective ...

Recommended for you

Ebola vaccine promising in first human trials

3 hours ago

Researchers say they are one step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

6 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

EU calls for 5,000 doctors to fight Ebola

7 hours ago

The European Commission called for 5,000 doctors to be sent from EU states to combat west Africa's Ebola epidemic, a European source with knowledge of the matter said on Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.